LMO1 and acute lymphoblastic leukemia: One concern for targeting USP7 in T-ALL emerges from recent observations of frequent loss-of-function mutations in USP7 found in pediatric leukemia, especially in TAL1/LMO1-positive T-ALL cases.38,49,50 The role of USP7 in these patients remains enigmatic.